Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System-Reference-Cited by-同舟云学术

Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System

Published:2022-06-22 Issue:7 Volume:5 Page:3371-3383
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Miranda Renata Rank¹^ORCID,Ferreira Natália Noronha¹,Souza Edmarcia Elisa de²,Lins Paula Maria Pincela¹^ORCID,Ferreira Leonardo Miziara Barboza¹,Krüger Arne²^ORCID,Cardoso Valéria Maria de Oliveira¹,Durigon Edison Luiz²,Wrenger Carsten²^ORCID,Zucolotto Valtencir¹^ORCID

Affiliation:

1. Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

2. Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes 1374, 05508-000 Sao Paulo, Sao Paulo, Brazil

Funder

Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Publisher

American Chemical Society (ACS)

Subject

Biochemistry (medical),Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.2c00349

Reference69 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study